Abstract
In this COVID era, when many struggle to work remotely, methotrexate (MTX) has been doing so all along. In this issue of Cell Host & Microbe, Nayak et al. discover that MTX reduces immune activation due to off-target effects on the gut microbiota, potentially explaining MTX's anti-inflammatory effects.
Original language | English (US) |
---|---|
Pages (from-to) | 325-326 |
Number of pages | 2 |
Journal | Cell Host and Microbe |
Volume | 29 |
Issue number | 3 |
DOIs | |
State | Published - Mar 10 2021 |
Externally published | Yes |
ASJC Scopus subject areas
- Parasitology
- Microbiology
- Virology